JP2005500996A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005500996A5 JP2005500996A5 JP2002586888A JP2002586888A JP2005500996A5 JP 2005500996 A5 JP2005500996 A5 JP 2005500996A5 JP 2002586888 A JP2002586888 A JP 2002586888A JP 2002586888 A JP2002586888 A JP 2002586888A JP 2005500996 A5 JP2005500996 A5 JP 2005500996A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- carboxylate
- formyl
- amino
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 37
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 18
- 150000007942 carboxylates Chemical class 0.000 claims 16
- -1 sulfonyloxy Chemical group 0.000 claims 15
- 125000000217 alkyl group Chemical group 0.000 claims 14
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 14
- 125000003282 alkyl amino group Chemical group 0.000 claims 10
- 150000003857 carboxamides Chemical class 0.000 claims 9
- 125000002252 acyl group Chemical group 0.000 claims 8
- 125000004663 dialkyl amino group Chemical group 0.000 claims 8
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 239000001257 hydrogen Substances 0.000 claims 7
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 claims 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 5
- 125000004442 acylamino group Chemical group 0.000 claims 5
- 125000004103 aminoalkyl group Chemical group 0.000 claims 5
- 108090000790 Enzymes Proteins 0.000 claims 4
- 102000004190 Enzymes Human genes 0.000 claims 4
- 102000015696 Interleukins Human genes 0.000 claims 4
- 108010063738 Interleukins Proteins 0.000 claims 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 4
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 claims 4
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 claims 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 150000001408 amides Chemical class 0.000 claims 3
- 125000004093 cyano group Chemical group *C#N 0.000 claims 3
- 150000002148 esters Chemical class 0.000 claims 3
- 150000002431 hydrogen Chemical class 0.000 claims 3
- 239000003112 inhibitor Substances 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000000651 prodrug Substances 0.000 claims 3
- 229940002612 prodrug Drugs 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- ASRMWYDEZPXXBA-UHFFFAOYSA-N (sulfonylamino)urea Chemical compound NC(=O)NN=S(=O)=O ASRMWYDEZPXXBA-UHFFFAOYSA-N 0.000 claims 2
- 125000004414 alkyl thio group Chemical group 0.000 claims 2
- 125000000266 alpha-aminoacyl group Chemical group 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 1
- 208000004429 Bacillary Dysentery Diseases 0.000 claims 1
- 108090000426 Caspase-1 Proteins 0.000 claims 1
- 206010063837 Reperfusion injury Diseases 0.000 claims 1
- 206010040070 Septic Shock Diseases 0.000 claims 1
- 206010040550 Shigella infections Diseases 0.000 claims 1
- 208000006011 Stroke Diseases 0.000 claims 1
- 125000004423 acyloxy group Chemical group 0.000 claims 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000005602 azabenzimidazolyl group Chemical group 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 239000004202 carbamide Substances 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 229910052736 halogen Inorganic materials 0.000 claims 1
- 150000002367 halogens Chemical class 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims 1
- 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000036303 septic shock Effects 0.000 claims 1
- 201000005113 shigellosis Diseases 0.000 claims 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 claims 1
- 229940124530 sulfonamide Drugs 0.000 claims 1
- 150000003456 sulfonamides Chemical class 0.000 claims 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims 1
- 125000006296 sulfonyl amino group Chemical group [H]N(*)S(*)(=O)=O 0.000 claims 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims 1
- 125000000147 tetrahydroquinolinyl group Chemical group N1(CCCC2=CC=CC=C12)* 0.000 claims 1
- 125000004001 thioalkyl group Chemical group 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28995001P | 2001-05-10 | 2001-05-10 | |
| PCT/US2002/015002 WO2002089749A2 (en) | 2001-05-10 | 2002-05-10 | Arylsulfonamide ethers, and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2005500996A JP2005500996A (ja) | 2005-01-13 |
| JP2005500996A5 true JP2005500996A5 (https=) | 2005-12-22 |
Family
ID=23113875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002586888A Pending JP2005500996A (ja) | 2001-05-10 | 2002-05-10 | アリールスルホンアミドエーテルおよびそれの使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US6875765B2 (https=) |
| EP (1) | EP1392280A4 (https=) |
| JP (1) | JP2005500996A (https=) |
| AU (1) | AU2002305552A1 (https=) |
| CA (1) | CA2445923A1 (https=) |
| MX (1) | MXPA03010179A (https=) |
| WO (1) | WO2002089749A2 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8420699B1 (en) | 2002-06-19 | 2013-04-16 | Irvine L. Dubow | Composition and methods of treatment using deionized and ozonated solution |
| US7897642B1 (en) * | 2002-06-19 | 2011-03-01 | Dr. Irvine Dubow | Compositions and methods for dry eye syndrome |
| US20050011464A1 (en) * | 2003-07-14 | 2005-01-20 | The Chinese University Of Hong Kong | Additive composition for feeding aquaculture animals and feed containing the same |
| US8193389B2 (en) | 2004-03-11 | 2012-06-05 | Elan Pharmaceuticals, Inc. | N-substituted benzene sulfonamides |
| MXPA06013256A (es) | 2004-05-15 | 2007-02-08 | Vertex Pharma | Tratamiento de crisis convulsivas utilizando inhibidores ice. |
| CA2567080A1 (en) | 2004-05-27 | 2005-12-15 | Vertex Pharmaceuticals Incorporated | Ice inhibitors for the treatment of autoinflammatory diseases |
| BRPI0820171B8 (pt) | 2007-11-16 | 2021-05-25 | Rigel Pharmaceuticals Inc | compostos de carboxamida, sulfonamida e amina para distúrbios metabólicos, composição farmacêutica, e, uso dos mesmos |
| CA2707047C (en) | 2007-12-12 | 2017-11-28 | Rigel Pharmaceuticals, Inc. | Carboxamide, sulfonamide and amine compounds for metabolic disorders |
| US20090185995A1 (en) * | 2008-01-18 | 2009-07-23 | Stacy Vochecowicz | Lubricious, non-tacky personal lubricant |
| US9969751B2 (en) * | 2009-06-10 | 2018-05-15 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
| WO2011094426A1 (en) | 2010-01-29 | 2011-08-04 | The United State Of America, As Represented By The Secretary, Department Of Health & Human Services | Caspase inhibitors |
| US9116157B2 (en) | 2010-11-05 | 2015-08-25 | Brandeis University | Ice-cleaved alpha-synuclein as a biomarker |
| CA2854266A1 (en) | 2011-11-30 | 2013-06-06 | Actelion Pharmaceuticals Ltd | 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics |
| CN109879817B (zh) * | 2019-03-19 | 2020-10-02 | 扬州大学 | 甲基二磺隆的制备方法 |
| CN118191186B (zh) * | 2024-05-16 | 2024-07-23 | 西南林业大学 | 一种水体中磺胺类抗生素的提取方法及其应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2268103A1 (en) * | 1996-10-11 | 1998-04-23 | Warner-Lambert Company | Sulfonamide substituted aspartic acid interleukin-1.beta. converting enzyme inhibitors |
-
2002
- 2002-05-10 US US10/143,675 patent/US6875765B2/en not_active Expired - Fee Related
- 2002-05-10 AU AU2002305552A patent/AU2002305552A1/en not_active Abandoned
- 2002-05-10 JP JP2002586888A patent/JP2005500996A/ja active Pending
- 2002-05-10 WO PCT/US2002/015002 patent/WO2002089749A2/en not_active Ceased
- 2002-05-10 CA CA002445923A patent/CA2445923A1/en not_active Abandoned
- 2002-05-10 MX MXPA03010179A patent/MXPA03010179A/es unknown
- 2002-05-10 EP EP02734382A patent/EP1392280A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2005500996A5 (https=) | ||
| CA2516018A1 (en) | Hepatitis c inhibitor peptide analogs | |
| RU2008123839A (ru) | Соединение оксазола и фармацевтическая композиция | |
| JP2005526011A5 (https=) | ||
| CA2632626C (en) | Ester prodrugs of 2'-fluoro-2'-alkyl-2'-deoxycytidines and their use in the treatment of hcv infection | |
| WO2004020430A3 (fr) | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique | |
| JP2008509166A5 (https=) | ||
| RU2006147267A (ru) | Конденсированное гетероциклическое соединение | |
| JP2005511508A5 (https=) | ||
| RU98102128A (ru) | Производные бензо[g]хинолина | |
| JP2009534358A5 (https=) | ||
| CO5271666A1 (es) | Derivados de pirimidina | |
| KR880006247A (ko) | 티에노피리디논 및 이의 제조방법 | |
| ATE469128T1 (de) | Indole, die sich zur behandlung von mit dem androgenrezeptor in zusammenhang stehenden krankheiten eignen | |
| EP2289887A3 (en) | Epoxycarboxylic acid amides, azides and amino alcohols and processes for preparation of alpha-keto amides by using them | |
| JP2005511602A5 (https=) | ||
| RU2008127257A (ru) | Тризамещенные производные хиназолинона в качестве ваниллоидных антагонистов | |
| DK1515962T3 (da) | Fremgangsmåde til fremstilling af dioxaneddikesyreestere | |
| JP2006505541A5 (https=) | ||
| HRP20080107T3 (en) | Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom | |
| KR960031442A (ko) | 페닐시클로헥실카르복스아미드의 용도 | |
| HRP20031055B1 (hr) | Novi imunomodulirajući spojevi | |
| RU2008128566A (ru) | Органические соединения | |
| KR960029312A (ko) | N-아릴알킬페닐아세트아미드 유도체와 그의 제조방법 | |
| ES2167869T3 (es) | Procedimiento para preparar acidos nicotinicos. |